Digital Medication Management for a Safer Everyday Life

Enhancing the Health and Well-being of Medication Users in the Short and Long Term

At iZafe Group, our mission is to enhance the health and well-being of individuals both in the short and long term. By providing digital services and products, we strive to ensure that medications are taken correctly and at the right time, while effectively demonstrating the positive health outcomes associated with adherence. Additionally, we integrate valuable data from other sensors to further enhance the overall experience.

Dosell

Dosell is a patented medication robot designed to ensure safer medication management for individuals in their homes and residents in elderly care facilities.

As the consumption of medications increases, so does the risk of medication-related injuries. On average, 300 individuals in Sweden are admitted to hospitals every day due to medication errors, resulting in significant suffering for the affected individuals and substantial costs for society.

By automatically dispensing medications in individual pouches at the prescribed time, Dosell ensures that patients receive their medication at the right moment. Dosell also sends reminders for medication administration and can alert healthcare professionals in case of missed doses. This reduces the risk of overdosing, taking the wrong combination of medications, or not taking medication at all. Dosell serves as a reliable safety measure for patients and their caregivers, providing peace of mind and valuable assistance to healthcare providers.

Pilloxa

A powerful and customized app for clinical trials, enabling a new level of patient engagement and involvement.

Empower and motivate patients throughout the entire study with an innovative digital platform that provides real-time insights and improves data quality.

With our advanced technology, you can differentiate your offering and maximize the success of clinical trials by integrating a smart Pillbox.

Gain an advantage by leveraging real-time insights from patients and take a step towards better outcomes and more efficient studies.

About iZafe Group

iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.

The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company’s solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.

The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.

iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018.

News

Sjalvstandig Medicinering Hemtjanst 2
2024-11-18 09:00
iZafe Group AB (publ) ("iZafe") announces today that it has received a new confirmed order for an additional 1,000 Dosell units from its exclusive distributor in the Netherlands, TCCN. This strategically important order has a value of approximately...
News Corporate Information Sales Order English IR mfn-cus-health

Grupp Kollegor På Möte
2024-11-14 13:30
iZafe Group's CFO, Marius Sandberg, has today acquired 177,793 B-shares in the company at a value of SEK 34,909 (SEK 0.196 per share). The acquisition was completed today, November 14, bringing Marius Sandberg's total shareholding in iZafe to...
News Corporate Information Other Corporate Information English IR

Kvartalsrapport Bild
2024-11-01 08:30
iZafe Group AB (publ.) presents today, November 1, its report for the third quarter. Financial Performance in Summary Significant events during the quarter Significant events after the end of the quarter Comments from CEOIt is with great pleasure that...
News English Regulatory MAR Report Interim Q3 IR mfn-cus-health

iZafe Group

Current stock price for iZafe Group AB

Contact us

Do you have any questions or cannot find the information you are looking for? Get in touch and we will help you.

    Webbdesign av Comlog Webbyrå Stockholm